Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Vascular Endothelial Growth Factor - Research from Yamaguchi University, Medical Department has provided new information about vascular endothelial growth factor
Angiogenesis - New data from University of Texas, M.D. Anderson Cancer Center illuminate research in angiogenesis
Angiogenesis - Study data from A. Bozec et al provide new insights into angiogenesis
Cancer Gene Therapy - New findings from Second Military Medical University, International Joint Cancer Institute in the area of cancer gene therapy published
Neurosurgery - Scientists at National Hospital for Neurology and Neurosurgery publish research in neurosurgery
Vascular Endothelial Growth Factor - Research on vascular endothelial growth factor described by scientists at Kyoto University, Department of Respiratory Medicine
Vascular Endothelial Growth Factor - Research on vascular endothelial growth factor discussed by scientists at Gifu University, Department of Internal Medicine
Vascular Endothelial Growth Factor - Scientists at Johann Wolfgang Goethe University, Department of Dermatology discuss research in vascular endothelial growth factor
ARIAD Pharmaceuticals, Inc. - ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab
CIGNA - CIGNA Volunteer of the Year in Phoenix Gives Sight to the Needy
Pluristem Therapeutics Inc. - Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease